:: Volume 12, Issue 1 (Int J Mol Cell Med (In Progress) 2023) ::
Int J Mol Cell Med 2023, 12(1): 0-0 Back to browse issues page
Inflammatory Responses of Women with Polycystic Ovary Syndrome in Vitro Differ from Healthy Women
Fatemeh Rezayat1 , Mehri Hajiaghayi1 , Nazanin Ghasemi1 , Mehrnaz Mesdaghi1 , Fahimeh Ramezani Tehrani 2, Nariman Mosaffa1
1- Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , ramezani@endocrine.ac.ir
Abstract:   (143 Views)
Polycystic ovary syndrome is a low-grade inflammatory state with increased serum levels of TNF-α. The present study has compared the inflammatory responses to breast cancer cell lines in women with PCOS with healthy women. Peripheral blood mononuclear cells (PBMCs) isolated from 50 women with PCOS and 50 healthy controls were cultured in the trans-well co-culture system. These cells were stimulated with two distinct breast cancer cell lines. The proliferation of PBMCs, CD3+CD8+T cell percentages, and tumor necrosis factor-alpha (TNF-α) concentration were evaluated after 48 and 72 hours of incubation. TNF-α concentration and the proliferation rate of PBMCs after 48 hours of incubation significantly increased in the PCOS group. However, after 72 hours, TNF-α secretion significantly decreased in the PCOS group. The ability of PBMCs to produce TNF-α decreased gradually in women with PCOS. When the effects of low-grade inflammation and endocrine conditions on the cells decrease, the inability of PBMCs to create an inflammatory response will be altered.
Keywords: Inflammatory response, polycystic ovary syndrome, TNF╬▒, breast cancer
Full-Text [PDF 440 kb]   (18 Downloads)    
Type of Study: Original Article | Subject: Molecular & Cellular Immunology
Received: 2022/11/12 | Accepted: 2023/08/29 | Published: 2023/09/19


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 1 (Int J Mol Cell Med (In Progress) 2023) Back to browse issues page